Recommendation of the President – Treatment of patients with advanced colorectal cancer (ICD-10: C18-C20)
On 4 July 2022 the President of the Agency for Health Technology Assessment and Tariff System issued the following recommendation:
Recommendation No. 64/2022 of 4 July 2022 of the President of the Agency for Health Technology Assessment and Tariff System on the evaluation of Keytruda (pembrolizumab) under the drug programme: ,,Treatment of patients with advanced colorectal cancer (ICD-10: C18-C20).”